Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses’ Health Study and Nurses’ Health Study II

摘要

PurposeFindings from epidemiologic studies of oxidative stress biomarkers and breast cancer have been mixed; although no studies have focused on estrogen receptor-negative (ER−) tumors, which may be more strongly associated with oxidative stress. We examined pre-diagnostic plasma fluorescent oxidation products (FlOP), a global biomarker of oxidative stress, and risk of ER− breast cancer in a nested case-control study in the Nurses’ Health Study (NHS) and NHSII.